Official UK procurement notice
Supply of Whole Blood Collection System and Ancillary Processing Systems
Authority: NHS Blood and Transplant (Central government)
What is being bought
Published requirement descriptionNo description was published on the notice. See the official documents.
CPV: Blood bags · Blood plasma filters
How this framework works
From the published notice- Framework period
5 yrs 10 mo from 9 Jun 2017, Need for modification brought about by circumstances which a diligent contracting authority could not foresee. See sections VII2.1 and VII2.2
The lotProcurement structure
single lot · no lot value publishedLot #1Whole Blood Collection Systems (Lot 1) and Ancillary Processing Systems (Lot2)
The EuroBloodPack 2(EBP2) framework agreement has a duration of four years and is due to expire on the 9th June 2021. This Modification will extend the EBP2 Framework Agreement to 31st March 2023.
What it takes to wini
How this buyer will score bids.
The evaluation criteria and weights exactly as published on the notice, grouped by family (price, quality, social value and so on).
Evaluation split and conditions of participation as published; the tender pack may add morei
How this buyer will score bids.
The evaluation criteria and weights exactly as published on the notice, grouped by family (price, quality, social value and so on).
- “Supply of Whole Blood Collection System and Ancillary Processing Systems” is a framework: the contest is a place on its panel, not a single contract.
Procedure terms & legal framework
From the official record- Legal basis
- CELEX · 32014L0024 Public Contracts Regulations 2015 (Directive 2014/24/EU)
- Procurement category
- Goods
- Notice status
- Awarded
- Procurement threshold
- Unspecified in notice
- Regulatory regime
- Standard
- Commercial structure
- Framework agreement
- Who may use this agreement
- Not stated in the notice; call-off rights may be limited to the establishing authority
- Competition type
- Competitive procedure
- GPA / WTO covered
- Unspecified in notice
- Recurring procurement
- Unspecified in notice
- First published
- 10 May 2021, 22:55 BST
- Last source update
- 10 May 2021, 22:55 BST
- Authority reference
NHSBT0763- FTS notice number
2021/S 000-010192- Classification (CPV)
- Delivery area
- Official registry OCID
ocds-h6vhtk-02af41Find a Tender
How it was run
Official notice- Appointment period ends
- —
Timeline
9 Jun 2017 → 10 May 2021 · 2 dates- Contract starts9 Jun 2017, 00:00 BST
- Notice published10 May 2021, 22:55 BST
Commercial outcome & contract awards
Published awards, contracts and bid statistics, not a forecast1 suppliers are admitted to this framework without individual award values or dates, see the supplier list below.
Contracts
Contract 010192-2021-NHSBT0763-1
- Signed
- 9 Jun 2017
- Value
- £104,000,000
- Period
- 9 Jun 2017 – 31 Mar 2023
- Status
- active
- Change The EuroBloodPack 2(EBP2) framework agreement has a duration of four years and is due to expire on the 9th June 2021. This Modification will extend the EBP2 Framework until 31st March 2023. Due to the impact of Covid-19 and the support for the Convalescent Plasma (CVP) programme there has been a significant delay in the retendering the new supply and in developing the replacement International Blood Pack 1 (IBP1) Framework on time., Need for modification brought about by circumstances which a diligent contracting authority/entity could not foresee: This Modification Notice is to provide notice that the EBP2 is being modified in accordance with Regulation 72 .1. B and /or 72.1.C of the Public Contracts Regulations 2015. This is because of the continuing focus of the contracting authorities on the Covid-19 crisis (which no diligent contracting authority could have foreseen) has significantly reduced the technical support for a retender. The length of this time has been chosen so that the replacement Framework IBP1can be completed. The length of time of this extension is because any other interim arrangements would be in place for such a short duration that it would cause significant inconvenience and/ or substantial duplication of costs; along with causing significant technical barriers such as requirements of interchangeability or interoperability with existing equipment, services or installations procured under the initial procurement.
Contracting authority & participating public bodies
Dispute resolution & review bodies
- High Courts of JusticeReview body
Framework contractors & participating bidders
1 commercial party on the notice- MacoPharma GMP.b, Haemonetics S.A, Fresenius Kabi LimitedFramework contractor
Official documents & specifications
Official links; attachments are not copiedNo document links were published on the notice.